Skip to content

Evaluation of macular microcircular alteration induced by glaucoma topical drugs using high resolution scannning LASER ophthalmoscope (SLO)

Evaluation of macular microcircular alteration induced by glaucoma topical drugs using high resolution scannning LASER ophthalmoscope (SLO) - Evaluation of macular microcircular alteration induced by glaucoma topical drugs using high resolution scannning LASER ophthalmoscope (SLO)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000015254
Enrollment
160
Registered
2014-09-25
Start date
2014-10-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients with: glaucoma ocular hypertension

Interventions

To take images of the human ocular fundus using scannning LASER ophthalmoscope (SLO), laser speckle flowgraphy (LSFG), and optical coherence tomography (OCT) before and at 7days, 1 and 3months after s

Sponsors

Department of Ophthalmology & Visual Sciences, Kyoto University Graduate School of Medicine
Lead Sponsor
CANON INC.
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patient 1) Male or female older than 20 years-old 2) patients with glaucoma or ocular hypertension 3) Subjects who sign an informed consent form to participate in the clinical study

Exclusion criteria

Exclusion criteria: 1) Having any side-effects (hypersensitivity, rised intraocular pressure etc.) against mydriatics 2) Revealed narrow angle by slit-lamp examination 3) When a doctor accepted the middle-class above-mentioned cataract 4) Subjects who a doctor in attendance declares ineligible for any reason

Design outcomes

Primary

MeasureTime frame
Blood flow rate in macular capillaries before and at 7days, 1 and 3months after starting topical anti-glaucoma medications

Secondary

MeasureTime frame
Diameter of macular capillaries before and at 7days, 1 and 3months after starting topical anti-glaucoma medications

Countries

Japan

Contacts

Public ContactHideo Nakanishi

Kyoto University Graduate School of Medicine Ophthalmology & Visual Sciences

eye@med.kyoto-u.ac.jp+81-75-751-3248

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026